{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:02:07Z","timestamp":1767650527866},"edition-number":"0","reference-count":1,"publisher":"CRC Press","isbn-type":[{"type":"electronic","value":"9780429214943"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3,6]]},"DOI":"10.3109\/9780203012055-33","type":"book-chapter","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T05:51:47Z","timestamp":1362462707000},"page":"489-512","source":"Crossref","is-referenced-by-count":1,"title":["Use of mitoxantrone to treat multiple sclerosis"],"prefix":"10.3109","member":"301","reference":[{"key":"ref26","unstructured":"1. Alberts DS, Peng YM, Bowden GT, et al. Pharmacology of mitoxantrone: mode of action and pharmacokinetics. Invest New Drugs 1985; 3: 101\u20137 2. Faulds D, Balfour JA, Chrisp P, Langtry HD. Mitoxantrone: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs 1991; 41: 400\u201399 3. Lenk H, M\u00fcller U, Tanneberger S. Mitoxantrone: mechanisms of action, antitumor activity, pharmacokinetics, efficacy in the treatment of solid tumors and lymphomas, and toxicity. Anticancer Res 1987; 7: 1257\u201364 4. Koeller J, Eble M. Mitoxantrone: a novel anthracycline derivative. Clin Pharm 1998; 7: 574\u201381 5. Shenkenberg TD, Von Hoff D. Mitoxantrone: a new anticancer drug with significant clinical activity. Ann Intern Med 1986; 105: 67\u201381 6. Wang BS, Murdock KC, Lumanglas AL, et al. Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses. Int J Immunopharm 1987; 9: 733\u20139 7. Wang BS, Lumaglas AL, Ruszala-Mallon VM, et al. Induction of alloreactive immuno-suppression by 1,4-bis [ (2-aminoethyl )amino]-5,8-dihydroxy-9,10anthracenedione dihydrochloride (CL 232,468). Int J Immunopharmacol 1984; 6: 475\u201382 8. Schneider T, Kupiec-Weglinski J, Towpik E, et al. Mitoxantrone: an immunosuppressive agent potentially useful in organ transplantation. Fed Proc 1985; 44: 1681 9. Bisteau M, Devos G, Brucher JM, Gonsette RE. Prevention of subacute experimental allergic encephalomyelitis in guinea-pigs with desferrioxamine, isoprinosine and mitoxantrone. In Gonsette RE, Delmotte P, eds. Recent Advances in Multiple Sclerosis Therapy. International Congress Series. Amsterdam: Elsevier Science Publishers, 1989; 863: 299\u2013300 10. Levine S, Saltzman A. Regional suppression therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantrone. J Neuroimmunol 1986; 13: 175\u201381 11. Lublin FD, Lavasa M, Viti C, Knobler RL. Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. Clin Immunol Immunopathol 1987; 45: 122\u20138 12. Ridge SC, Sloboda AE, McReynolds RA, et al. Suppression of experimental allergic encephalomyelitis by mitoxantrone. Clin Immunol Immunopathol 1985; 35: 35\u201342 13. Watson CM, Davison AN, Baker D, et al. Suppression of demyelination by mitoxantrone. Int J Immunopharmacol 1991; 13: 923\u201330 14. Gonsette RE, Demonty L. Immunosuppression with mitoxantrone in multiple sclerosis: a pilot study for 2 years in 22 patients. Neurology 1990; 40 (Suppl 1): 261 (abstr 537P) 15. Kappos L, Gold R, K\u00fcnstler E, et al. Mitoxantrone in the treatment of rapidly progressive MS: a pilot study with serial gadolinium-enhanced MRI. Neurology 1990; 40 (Suppl 1): 261 (abstr 539P)"}],"container-title":["Multiple Sclerosis Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crcnetbase.com\/doi\/pdf\/10.3109\/9780203012055-33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T22:49:18Z","timestamp":1608763758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9780203012055\/chapters\/10.3109\/9780203012055-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,6]]},"ISBN":["9780429214943"],"references-count":1,"URL":"https:\/\/doi.org\/10.3109\/9780203012055-33","relation":{},"subject":[],"published":{"date-parts":[[2007,3,6]]}}}